Professional
Added to YB: 2024-02-29
Pitch date: 2024-01-30
ILMN [neutral]
Illumina, Inc.
+1.74%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$21.9B
Pitch Price
$142.35
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.85
P/E
26.28
EV/Sales
5.31
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
RiverPark Large Growth Fund Portfolio Holding - Illumina, Inc.
ILMN cut Q4 guide & sees flat 2024 amid China weakness, macro headwinds, academic cuts. Divesting Grail buoyed stock late. Genomics leader w/ <0.02% population sequenced, $5B TTM rev in $50B+ market implies early days of growth runway.
Read full article (1 min)